Role of immunoglobulin G3 subclass in dilated cardiomyopathy: Results from protein A immunoadsorption

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 729-736

  Staudt, Alexander ^a   Dörr, Markus ^a   Staudt, Yvonne ^a   Böhm, Marko ^b   Probst, Michael ^a   Empen, Klaus ^a   Plötz, Sebastian ^a   Maschke, Hans E ^c   Hummel, Astrid ^a   Baumann, Gert ^b   Felix, Stephan B ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c BioScience New Business Consulting   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G3; PROTEIN A;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; IMMUNOADSORPTION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADSORPTION; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES;

EID: 25844517240     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.11.002     Document Type: Article

References (32)

1. P. Richardson, W. McKenna, and M.J. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
2. H. Nishimura, T. Okazaki, and Y. Tanaka Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 2001 319 322
3. C.J. Limas, I.F. Goldenberg, and C. Limas Soluble interlein-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies Circulation 91 1995 631 634
4. P.L. Schwimmbeck, C. Badorff, and H.P. Schultheiss Transfer of human myocarditis into severe combined immunodeficiency mice Circ Res 75 1994 156 164
5. S.C. Smith, and P.M. Allen Myosin-induced acute myocarditis is a T-cell mediated disease J Immunol 147 1991 2141 2147
6. K. Schulze, B.F. Becker, and R. Schauer Antibodies to ADP-ATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function Circulation 81 1990 959 969
7. A.L. Caforio, M. Grazzini, and J.M. Mann Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy Circulation 85 1992 1734 1742
8. C.J. Limas, I.F. Goldenberg, and C. Limas Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy Circ Res 64 1989 97 103
9. Y. Magnusson, G. Wallukat, and F. Waagstein Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect Circulation 89 1994 2760 2767
10. L.X. Fu, Y. Magnusson, and C.H. Bergh Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy J Clin Invest 91 1993 1964 1968
11. S. Matsui, M.L. Fu, and S. Katsuda Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits J Mol Cell Cardiol 29 1997 641 655
12. T. Okazaki, Y. Tanaka, and R. Nishio Autoantibodies against troponin-I are responsible for dilated cardiomyopathy in PD-1 deficient mice Nat Med 9 2003 1477 1483
13. H.P. Schultheiss, U. Kuhl, and I. Janda Antibody-mediated enhancement of calcium permeability in cardiac myocytes J Exp Med 168 1988 2102 2119
14. W.V. Dorffel, S.B. Felix, and G. Wallukat Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy Circulation 95 1997 1994 1997
15. S.B. Felix, A. Staudt, and W.V. Dorffel Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study J Am Coll Cardiol 35 2000 1590 1598
16. J. Muller, G. Wallukat, and M. Dandel Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy Circulation 101 2000 385 391
17. S.B. Felix, A. Staudt, and M. Landsberger Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption J Am Coll Cardiol 39 2002 646 652
18. A. Staudt, M. Bohm, and F. Knebel Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients suffering from dilated cardiomyopathy Circulation 106 2002 2448 2453
19. A. Staudt, F. Schaper, and V. Stangl Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution Circulation 103 2001 2681 2686
20. M. Bruggemann, G.T. Williams, and C.I. Bindon Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies J Exp Med 166 1987 1351 1361
21. T.P. Zwaka, D. Manolov, and C. Ozdemir Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes Am J Pathol 161 2002 449 457
22. N. Braun, S. Gutenberger, and C.M. Erley Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein-A sepharose Transfus Sci 19 1998 25 31
23. A. Wong, T.P. Kenny, and R. Ermel IgG3 reactive rheumatoid factor in rheumatoid arthritis: etiologic and pathogenic considerations Autoimmunity 19 1994 199 210
24. A.H. Mulder, C.A. Stegeman, and C.G. Kallenberg Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA Clin Exp Immunol 101 1995 227 232
25. R.S. Warraich, M. Noutsias, and I. Kazak Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates Am Heart J 143 2002 1076 1084
26. 1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy J Autoimmun 423 2003 115 119
27. C. Roifman, H. Levison, and E. Gelfand High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease Lancet 1 1987 1075 1077
28. J. Dwyer Manipulating the immune system with immune globulin N Engl J Med 326 1992 107 116
29. A. Samuelsson, T.L. Towers, and J.V. Ravetch Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor Science 291 2001 484 486
30. K. Shioji, C. Kishimoto, and S. Sasayama Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells Circ Res 89 2001 540 546
31. L. Gullestad, H. Aass, and J.G. Fjeld Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure Circulation 103 2001 220 225
32. D.M. McNamara, R. Holubkov, and R.C. Starling Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy Circulation 103 2001 2254 2259